Impact of Positive and Negative Lesion Site Remodeling on Clinical Outcomes Insights From PROSPECT by Inaba, Shinji et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 7 , N O . 1 , 2 0 1 4
ª 2 0 1 4 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 3 . 1 0 . 0 0 7Impact of Positive and Negative Lesion
Site Remodeling on Clinical Outcomes
Insights From PROSPECT
Shinji Inaba, MD,*y Gary S. Mintz, MD,* Naim Z. Farhat, MD,z Jean Fajadet, MD,x
Dariusz Dudek, MD,k Antonio Marzocchi, MD,{ Barry Templin, MBA,#
Giora Weisz, MD,*y Ke Xu, PHD,* Bernard de Bruyne, MD, PHD,**
Patrick W. Serruys, MD, PHD,yy Gregg W. Stone, MD,*y Akiko Maehara, MD*y
New York, New York; Elyria, Ohio; Toulouse, France; Krakow, Poland; Bologna, Italy;
Santa Clara, California; Aalst, Belgium; and Rotterdam, the NetherlandsOBJECTIVES This study investigated coronary artery remodeling patterns associated with clinical
outcomes.
BACKGROUND In the prospective, multicenter PROSPECT (Providing Regional Observations to
Study Predictors of Events in the Coronary Tree: An Imaging Study in Patients With Unstable Atheroscle-
rotic Lesions) study, reported predictors of nonculprit lesion (NCL) major adverse cardiac events (MACE)
were an intravascular ultrasound (IVUS) minimal lumen area (MLA) #4 mm2, a plaque burden $70%, and
a IVUS–virtual histology (VH) thin-cap ﬁbroatheroma (TCFA), but not lesion site remodeling.
METHODS Overall, 697 consecutive patients with an acute coronary syndrome were enrolled and
underwent 3-vessel gray-scale and IVUS-VH; 3,223 NCLs were identiﬁed by IVUS. The remodeling index
(RI) was calculated as the external elastic membrane area at the MLA site divided by the average of the
proximal and distal reference external elastic membrane areas. First, one third of the patients were
randomly selected to determine RI cutoffs related to NCL MACE (development cohort). Receiver-
operating characteristic analysis showed that there were 2 separate cut points that predicted NCL
MACE: RI ¼ 0.8789 and RI ¼ 1.0046 (area under the curve ¼ 0.663). These cut points were used to deﬁne
negative remodeling as an RI <0.88, intermediate remodeling as an RI of 0.88 to 1.00, and positive
remodeling as an RI >1.00. Second, we used the remaining two-thirds of patients to validate these
cut points with respect to lesion morphology and clinical outcomes (validation cohort).
RESULTS Kaplan-Meier curve analysis in the validation cohort showed that NCL MACE occurred more
frequent (and equally) in negative and positive remodeling lesions compared with intermediate remod-
eling lesions. In this cohort, negative remodeling lesions had the smallest MLA, positive remodeling
lesions had the largest plaque burden, and VH TCFA, especially VH TCFA with multiple necrotic cores,
was most common in negatively remodeling lesions.
CONCLUSIONS The present study showed the novel concept that positive and negative lesion site
remodeling was associated with unanticipated NCL MACE in the PROSPECT study. (PROSPECT: An
Imaging Study in Patients With Unstable Atherosclerotic Lesions [PROSPECT]; NCT00180466) (J Am
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71revious studies showed that a positive
remodeling (lesion site external elastic mem-A B B R E V I A T I O N S
A N D A C R O N YM S
CSA = cross-sectional
DC = dense calcium
EEM = external elastic
membrane
FF = ﬁbrofatty
FT = ﬁbrotic
IVUS = intravascular ultrasound
MLA = minimal lumen area
NCL MACE = nonculprit lesion
major adverse cardiac event(s)
NC = necrotic core
RI = remodeling index
ROC = receiver-operating
characteristic
TCFA = thin-cap ﬁbroatheroma
ThCFA = thick-cap
ﬁbroatheroma
VH = virtual histologybrane [EEM] area greater than the reference
segments) is more common in culprit lesions
in patients presenting with acute coronary syndrome
and is seen in association with plaque rupture, yellow
plaque color, and thrombus formation; conversely,
negative remodeling (lesion EEM less than the
reference segments) is more common in target lesions
in patients presenting with stable symptoms (1–4).
Nevertheless and surprisingly, in the prospective,
multicenter PROSPECT (Providing Regional Ob-
servations to Study Predictors of Events in the Cor-
onary Tree: An Imaging Study in Patients With
UnstableAtheroscleroticLesions) study, predictors of
nonculprit lesion (NCL)major adverse cardiac events
(MACE) were an intravascular ultrasound (IVUS)
minimal lumen area (MLA) #4 mm2, a plaque
burden $70%, and a radiofrequency IVUS–virtual
histology (VH) thin-cap ﬁbroatheroma (TCFA), but
not positive remodeling (5). Hibi et al. (6) showed
that the frequency of positive remodeling was entirely
dependent on the deﬁnition used. Therefore, we hy-
pothesized that the lack of association between
remodeling and NCL MACE in the PROSPECT
study could be attributed to the approach used to
assess remodeling and the deﬁnitions used to separate
lesions into positive and negative remodeling.
METHODS
Protocol design. The PROSPECT study design,
major inclusion and exclusion criteria, endpoints, and
deﬁnitions have been described (5). In brief, 697
consecutive patients with acute coronary syndrome
(ST-segment elevation myocardial infarction beyond
24 h, non–ST-segment elevation myocardial infarc-
tion, or moderate to high-risk unstable angina) were
enrolled only after successful and uncomplicated
percutaneous coronary intervention of all coronary
lesions responsible for the index event and after
completion of any other planned interventions.
Three-vessel gray-scale and IVUS-VH intracoron-
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was performed with the use of a synthetic aperture-
array, 20-MHz, 3.2-French catheter (Eagle Eye,
Volcano Corporation, Rancho Cordova, California)
and motorized catheter pullback (0.5 mm/s). The
study was approved by the institutional review
board at each participating center, and all patients
signed informed, written consent.
Imaging analysis. Core laboratory off-line gray-
scale and IVUS-VH analyses were performed with
the use of QCU-CMS software (Medis, Leiden, the
Netherlands) for contouring, pcVH 2.1 software
(Volcano Corporation) for contouring and data
output, and proprietary qVH software (Cardiovas-
cular Research Foundation, New York, New York)
for segmental qualitative assessment and quantita-
tive data output. All baseline IVUS images
were prospectively analyzed without
knowledge of subsequent events. An IVUS
NCL was deﬁned as having >3 consecu-
tive slices with $40% plaque burden.
The EEM and luminal borders were
contoured for each frame. Gray-scale IVUS
measurements included the cross-sectional
areas (CSA) of the EEM, lumen, and pla-
que and media (plaque and media ¼
EEM lumen) and plaque burden (plaque
andmediaOEEM). Volumetric gray-scale
and IVUS-VH analyses were performed
using Simpson’s rule. Area stenosis was
calculated by the following formula: 1 
(MLA O the average of the proximal and
distal reference lumen CSA).
The remodeling index (RI) was calcu-
lated as the EEM CSA at the MLA site
O the average of the proximal and distal
reference segment EEM CSAs.
Developmental and validation cohorts to
determine RI cutoffs related to NCL MACE. During
the process of evaluation in this entire cohort, we
recognized that there might be >1 RI cutoff that
was predictive of NCL MACE. Therefore, we ﬁrst
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72patients to develop the cutoff values that predicted
NCL MACE (development cohort). Second, we
tested these remodeling cutoff values in the
remaining two-thirds of patients (validation cohort)
including both lesion morphology and NCL
MACE.
IVUS-VH phenotype classiﬁcation. IVUS-VH pla-
que components were color coded as dense calcium
(DC, white), necrotic core (NC, red), ﬁbrofatty (FF,
light green), or ﬁbrotic (FT, dark green). Lesions
were further classiﬁed by means of IVUS-VH as one
of the following: VH-TCFA, thick-cap ﬁbroather-
oma (ThCFA), pathological intimal thickening,
ﬁbrotic plaque, or ﬁbrocalciﬁc plaque. Fibroather-
oma (both VH-TCFA and ThCFA) was deﬁned
as >10% conﬂuent NC. VH-TCFA was a ﬁbroa-
theroma without evidence of a ﬁbrous cap with
>30 of NC abutting to the lumen in at least
3 consecutive slices. ThCFA was a ﬁbroatheroma
with a deﬁnable ﬁbrous cap. Pathological intimal
thickening had a mixture of all plaque components,
but dominantly FF plaque with <10% conﬂuent
NC and <10% conﬂuent DC. Fibrotic plaque
had mainly FT with <10% conﬂuent NC, <10%
conﬂuent DC, and <15% FF plaque. Fibrocalciﬁc
plaque had mainly FT with >10% conﬂuent DC,Baseline Clinical Characteristics of the Patients (N [ 660)
58.1 (50.7–66.7)
77.0 (508/660)
s index, kg/m2 28.0 (25.2–31.2)
17.2 (113/657)
syndrome 48.3 (308/638)
igarette use 47.8 (311/651)
sion 46.6 (305/654)
emia 44.9 (270/601)
myocardial infarction 10.7 (70/656)
percutaneous coronary interventions 10.8 (71/659)
esentation
30.0 (198/660)
EMI 66.2 (437/660)
le angina 3.8 (25/660)
am Risk Score 7.0 (5.0–9.0)
ol, mg/dl
nsity lipoprotein 100.8 (79.2–127.4)
nsity lipoprotein 38.6 (34.0–46.0)
5.7 (5.3–6.2)
fﬁciency 9.8 (61/623)
itivity C-reactive protein at 30 days, mg/dl 1.8 (0.8–4.0)
median (interquartile range) or % (number of observations/total number of
enal insufﬁciency is deﬁned as estimated creatinine clearance #60 ml/min.
glycosylated hemoglobin; STEMI ¼ ST-segment elevation myocardial infarction.but <10% conﬂuent NC. Fibroatheromas (VH-
TCFA or ThCFA) were subclassiﬁed as having
single or multiple conﬂuent NCs with or without
DC.
Clinical endpoints and deﬁnitions. The pre-speciﬁed
primary endpoint was the incidence of MACE,
deﬁned as the composite of death due to cardiac
causes, cardiac arrest, myocardial infarction, or reho-
spitalization due to unstable or progressive angina
according to the Braunwald Unstable Angina Clas-
siﬁcation and the Canadian Cardiovascular Society
Angina Classiﬁcation. The primary endpoint was
adjudicated by an independent clinical events com-
mittee. On the basis of follow-up angiography,
MACE was attributed to an NCL site if the site
associated with an event was previously untreated.
If follow-up angiography was not performed, the
lesion site was classiﬁed as indeterminate and
excluded from this analysis.
Statistical analysis. Statistical analysis was per-
formed with SAS software, version 9.2 (SAS
Institute, Cary, North Carolina). Categorical vari-
ables were summarized using counts and percent-
ages. Continuous variables for baseline clinical
characteristics were displayed as median and ﬁrst
and third interquartile range. For lesion level data, a
model with a generalized estimating equation
approach was used to compensate for any potential
cluster effect of multiple lesions in the same patient
and presented as least square means with 95%
conﬁdence intervals. Receiver-operating character-
istic (ROC) cut points were selected as the points
farthest away from but on a line perpendicular to
the unity line to measure the ability of the RI to
discriminate between the lesions with and
those without NCL MACE. The ROC curves
plot the probability of detecting true-positive frac-
tion (sensitivity) against false-positive fraction
(1-speciﬁcity) of 3-year NCL MACE over the
entire range of the observed RI. Time-to-event data
were presented as Kaplan-Meier estimates and
compared with the generalized estimating equation
proportional hazards model. Multivariate Cox
regression models using the entire cohort were used
to determine the independent predictor of NCL
MACE including the previously published lesion-
related variables. A p value <0.05 was considered
to indicate statistical signiﬁcance.
RESULTS
Patient characteristics in the entire cohort. Overall,
3,223 gray-scale IVUS lesions in 660 patients were
identiﬁed. IVUS-VH data were also available for
Figure 2. Kaplan-Meier Curves for MACE During 3-Year Follow-up i
The 3-year cumulative rates of nonculprit lesion MACE were similarly hig
death from cardiac causes, cardiac arrest, myocardial infarction, and reh
estimating equation; MACE ¼ major adverse cardiac events; R ¼ remo
Figure 1. Receiver-Operating Characteristic Curve of RI and
Nonculprit Lesion Major Adverse Cardiac Events in the
Developmental Cohort
The receiver-operating characteristic curve showed 2 different
cutoff values of the remodeling index (RI): 0.8789 and 1.0046.
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732,874 lesions. Baseline clinical characteristics of the
patients are listed in Table 1. The median age was
58.1 years, and 77.0% were men.
RI cutoffs related to NCL MACE in the developmental
cohort. ROC curve analysis using a randomly
selected cohort of one-third of the patients in the
PROSPECT study (n ¼ 217, 1,041 lesions)
showed that there were 2 separate cutoff points
(RI ¼ 0.8789 and RI ¼ 1.0046, area under the
curve ¼ 0.663 for this model) that predicted NCL
MACE (Fig. 1). Accordingly, we divided PROS-
PECT NCLs into 3 groups using these 2 cutoff
points; RI <0.88 (negative remodeling), RI ¼ 0.88
to # 1.00 (intermediate remodeling), and RI >1.00
(positive remodeling).
Validation of RI cutoffs. In the remaining two-thirds
of the patients in the PROSPECT study (n ¼ 443
patients and 2,182 lesions), Kaplan-Meier curves
conﬁrmed that events occurred more frequently
(and equally) in positive and negative remodeling
lesions compared with intermediate remodeling
lesions, as deﬁned in the developmental cohort
(p ¼ 0.025) (Fig. 2). NCL MACE occurred inn Nonculprit Lesions in the Validation Cohort
her in positive and negative remodeling lesions. MACE was deﬁned as
ospitalization for unstable or progressive angina. GEE ¼ generalized
deling; RI ¼ remodeling index.
Table 2. Nonculprit Lesion Events at the Lesion Level (2,182 Lesions in 443 Patients)
RI p Value
RI < 0.88
(NR, n [ 734)
0.88 £ RI £ 1.00
(IR, n [ 911)
1.00 < RI
(PR, n [ 537) NR vs. IR NR vs. PR PR vs. IR
Cardiac death 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) N/A N/A N/A
Cardiac arrest 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) N/A N/A N/A
Myocardial infarction 0.1 (1.0) 0.0 (0.0) 0.0 (0.0) <0.0001 <0.0001 N/A
Rehospitalization 2.0 (13.0) 0.7 (6.0) 2.5 (12.0) 0.03 0.49 0.008
Due to unstable angina 0.9 (6.0) 0.0 (0.0) 0.6 (3.0) <0.0001 0.60 <0.0001
Due to progressive angina 1.0 (7.0) 0.7 (6.0) 1.9 (9.0) 0.46 0.19 0.07
Composite major adverse cardiac events 2.1 (14.0) 0.7 (6.0) 2.5 (12.0) 0.02 0.63 0.008
Events rate are shown as Kaplan-Meier estimate percentage (number of events).
IR ¼ intermediate remodeling; N/A ¼ not applicable; NR ¼ negative remodeling; PR ¼ positive remodeling; RI ¼ remodeling index.
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7432 patients: 1 myocardial infarction and 31 reho-
spitalizations during 3 years of clinical follow-up
(Table 2).
Gray-scale IVUS analysis in the validation cohort. Of
the 424 patients having at least 2 NCLs, 22 patients
(5.2%) had the same remodeling pattern in all
lesions, whereas 402 patients (94.8%) had lesions
with different remodeling patterns. The average
number of NCLs per patient in the validation
cohort was 4.9  2.0.
As shown in Figure 3 and Table 3, the MLA was
the smallest in negative remodeling lesions, with
no difference between positive and intermediateFigure 3. Difference of MLA and Plaque Burden at the MLA Site in
(Left) The MLA; MLA is smallest in negative remodeling lesions versus po
the MLA site; plaque burden at the MLA site is the least in intermediate
lesions. The plots are displayed as least-square means with error bar (9
negative remodeling. RI ¼ remodeling index.remodeling lesions. On the other hand, plaque
burden at the MLA site was the greatest in positive
remodeling lesions, although negative remodeling
lesions also had a greater plaque burden compared
with intermediate remodeling lesions (Fig. 3).
Negative remodeling lesions were the longest,
whereas intermediate remodeling lesions were the
shortest (Table 3).
IVUS-VH analysis in the validation cohort. IVUS-
VH volumetric analysis showed that the percent-
ages of NC and DC were signiﬁcantly greater in
negative remodeling lesions compared with the
other 2 remodeling patterns (Table 4), with similarRelation to Remodeling
sitive and intermediate remodeling lesions. (Right) Plaque burden at
remodeling lesions compared with positive and negative remodeling
5% CI). *p < 0.0001 versus positive remodeling; yp < 0.0001 versus
Table 3. Gray-Scale Intravascular Ultrasound Lesion Analysis (2,182 Lesions in 443 Patients)
RI p Value
RI < 0.88
(NR, n [ 734)
0.88 £ RI £ 1.00
(IR, n [ 911)
1.00 < RI
(PR, n [ 537) NR vs. IR NR vs. PR PR vs. IR
Minimal lumen area site
RI 0.77 (0.76–0.78) 0.94 (0.94–0.95) 1.07 (1.06–1.07) <0.0001 <0.0001 <0.0001
Lumen CSA, mm2 5.5 (5.3–5.7) 7.0 (6.8–7.2) 6.8 (6.5–7.1) <0.0001 <0.0001 0.21
Minimum lumen area #4 mm2 31.1 (228) 13.8 (126) 16.6 (89) <0.0001 <0.0001 0.16
Area stenosis, % 38.1 (37.0–39.2) 21.7 (20.7–22.7) 20.9 (19.8–22.0) <0.0001 <0.0001 0.25
Plaque burden, % 56.5 (55.8–57.2) 54.2 (53.5–54.8) 59.2 (58.4–60.0) <0.0001 <0.0001 <0.0001
Plaque burden $70% 7.4 (54) 5.2 (47) 14.2 (76) 0.10 <0.0001 <0.0001
EEM CSA at minimal lumen area, mm2 12.8 (12.4–13.1) 15.3 (14.9–15.7) 16.7 (16.1–17.3) <0.0001 <0.0001 <0.0001
EEM CSA at proximal reference, mm2 19.3 (18.8–19.9) 16.8 (16.3–17.2) 16.2 (15.6–16.7) <0.0001 <0.0001 0.04
EEM CSA at distal reference, mm2 13.9 (13.4–14.4) 15.6 (15.2–16.1) 15.2 (14.7–15.8) <0.0001 <0.0001 0.17
Volumetric analysis
Lesion length, mm 21.8 (20.6–23.0) 12.5 (11.7–13.3) 13.9 (12.8–15.1) <0.0001 <0.0001 0.04
Plaque burden, % 49.1 (48.7–49.6) 47.2 (46.8–47.7) 48.9 (48.4–49.5) <0.0001 0.60 <0.0001
Mean EEM CSA, mm3/mm 15.8 (15.4–16.3) 16.2 (15.7–16.6) 16.3 (15.7–16.8) 0.21 0.15 0.74
Mean lumen CSA, mm3/mm 8.1 (7.8–8.3) 8.5 (8.3–8.8) 8.3 (8.0–8.6) 0.004 0.20 0.15
Mean plaque and media CSA, mm3/mm 7.8 (7.5–8.0) 7.7 (7.4–7.9) 8.0 (7.7–8.3) 0.46 0.16 0.03
Morphological analysis
Plaque rupture 3.1 (23) 2.0 (18) 3.2 (17) 0.15 0.99 0.14
Values are generalized estimating equation least-square means (95% CI) or percentage (number of observations).
CSA ¼ cross-sectional area; EEM ¼ external elastic membrane; other abbreviations as in Table 2.
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75ﬁndings for planar IVUS-VH analysis at the MLA
site.
The analysis of lesion phenotype is shown in
Table 4. The frequency of any ﬁbroatheroma
(combining VH-TCFA and ThCFA) was higher in
negative and tended to be higher in positive
remodeling lesions compared with intermediate
remodeling lesions (negative remodeling vs. positive
remodeling, p < 0.0001; negative remodeling vs.
intermediate remodeling, p < 0.0001; intermediate
remodeling vs. positive remodeling, p ¼ 0.08). VH-
TCFA was identiﬁed most frequently in negative
remodeling lesions (negative remodeling vs. positive
remodeling, p ¼ 0.03; negative remodeling vs. in-
termediate remodeling, p ¼ 0.003; intermediate
remodeling vs. positive remodeling, p ¼ 0.60). In
addition, the frequency of VH-TCFA or ThCFA
with multiple conﬂuent NCs was more frequent
in lesions with negative remodeling than positive
remodeling (VH-TCFA, p ¼ 0.01; ThCFA, p ¼
0.007).
Independent predictors of NCL MACE in the entire
cohort. Independent predictors of NCL MACE at
the lesion level are given in Table 5. In addition to
previously published PROSPECT predictors ofMACE (large plaque burden, VH-TCFA, and
small lumen area), both positive remodeling and
negative remodeling were independent predictors of
subsequent NCL MACE.
D I SCUSS ION
The present study suggests that the common
approach of separating lesions into positive and
negative remodeling or using arbitrary deﬁnitions
may be too simplistic, especially when applied to
NCLs. Instead, lesions at both ends of the remod-
eling spectrum may be most associated with future
events. The present study introduced the novel
concept that bidirectional remodeling was related to
NCL MACE.
Determinant factors of remodeling patterns.
Previous studies suggested a link between each
remodeling pattern and systemic risk factors; for
example, smoking and insulin-treated diabetes were
associated with negative remodeling, and hyperlip-
idemia was associated with positive remodeling
(7,8). In the present study, the majority of patients
(94.8%) had different lesion-related remodeling
patterns, and only a small minority had a single
Table 4. Virtual Histology Intravascular Ultrasound Lesion Analysis (1,943 Lesions in 410 Patients)
RI p Value
RI < 0.88
(NR, n [ 646)
0.88 £ RI £ 1.00
(IR, n [ 822)
1.00 < RI
(PR, n [ 475) NR vs. IR NR vs. PR PR vs. IR
Minimal lumen area site, %
Necrotic core 15.2 (14.2–16.1) 13.0 (12.1–13.8) 13.3 (12.3–14.4) <0.0001 0.001 0.49
Dense calcium 7.7 (6.9–8.5) 5.9 (5.2–6.5) 5.6 (4.9–6.3) <0.0001 <0.0001 0.50
Fibrous tissue 59.0 (57.9–60.0) 60.1 (59.2–61.1) 59.8 (58.7–60.9) 0.08 0.23 0.56
Fibrofatty 18.2 (17.0–19.3) 21.0 (19.9–22.1) 21.4 (20.1–22.7) <0.0001 <0.0001 0.59
Volumetric analysis, %
Necrotic core volume 13.8 (13.0–14.6) 12.4 (11.6–13.1) 12.6 (11.7–13.4) 0.0002 0.004 0.63
Dense calcium volume 7.2 (6.6–7.8) 6.0 (5.4–6.5) 6.2 (5.5–6.8) <0.0001 0.003 0.58
Fibrous tissue volume 58.6 (57.8–59.4) 60.1 (59.3–60.9) 60.1 (59.1–61.0) 0.0006 0.003 0.96
Fibrofatty volume 20.5 (19.4–21.5) 21.5 (20.5–22.6) 21.2 (20.1–22.4) 0.03 0.17 0.59
Lesion phenotype
Virtual histology derived thin-cap ﬁbroatheroma 27.2 (176) 19.8 (163) 20.2 (96) 0.003 0.03 0.60
With multiple conﬂuent necrotic core 20.9 (135) 13.9 (114) 14.3 (68) 0.003 0.01 0.72
With single conﬂuent necrotic core 6.3 (41) 6.0 (49) 5.9 (28) 0.73 0.83 0.92
With dense calcium 10.1 (65) 5.7 (47) 4.4 (21) 0.007 0.002 0.41
Thick-cap ﬁbroatheroma 44.3 (286) 33.5 (275) 37.7 (179) <0.0001 0.03 0.15
With multiple conﬂuent necrotic core 32.2 (208) 21.3 (175) 24.2 (115) <0.0001 0.007 0.22
With single conﬂuent necrotic core 12.1 (78) 12.2 (100) 13.5 (64) 0.92 0.56 0.58
With dense calcium 32.4 (209) 21.5 (177) 25.1 (119) <0.0001 0.01 0.21
Any ﬁbroatheroma 71.5 (462) 53.3 (438) 57.9 (275) <0.0001 <0.0001 0.08
Pathological intimal thickening 25.1 (162) 42.5 (349) 39.6 (188) <0.0001 <0.0001 0.33
Fibrotic plaque 2.2 (14) 3.2 (26) 2.1 (10) 0.27 0.95 0.29
Fibrocalciﬁc plaque 1.2 (8) 1.1 (9) 0.4 (2) 0.81 0.18 0.22
Values are generalized estimating equation least-square means (95% CI) or percentage (number of observations).
Abbreviations as in Table 2.
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76remodeling pattern across all lesions. This clearly
indicates that remodeling is more of a lesion-speciﬁc
response and less determined primarily by patient
characteristics. Our data conﬁrm the previous
ﬁndings indicating heterogeneity in remodeling
response, even with the same patient (9).
Positive remodeling. On the one hand, positive
remodeling in response to plaque growth helps to
prevent luminal narrowing (10); on the other hand,
positive remodeling may be a marker for plaque
vulnerability. Pathological studies revealed that
plaques with positive remodeling have a larger
lipid core and a greater macrophage burden typical
of a rupture-prone TCFA (11,12) and consistent
with previous IVUS studies in which: 1) positive
remodeling is seen in patients who have a more
unstable clinical presentation (4); and 2) ruptured
plaque sites show more positive remodeling com-
pared with MLA sites (13). Previous studies alsosuggest that positive remodeling predicts: 1) creatine
kinase-myocardial band elevation after percuta-
neous coronary intervention (14); 2) no reﬂow in
primary infarct angioplasty (15); 3) recurrent
ischemia within 1 month after thrombolysis for acute
myocardial infarction (16); 4) target lesion revascu-
larization in patients undergoing nonstent inter-
vention (17); 5) MACE in patients with unstable
angina undergoing any form of revascularization
(18); 6) target vessel revascularization and intimal
hyperplasia in patients undergoing bare metal
stenting (19,20); 7) intimal hyperplasia after im-
plantation of drug-eluting stents (21); and 8) in-
hospital complications, MACE, restenosis, and
new lesion formation in patients with stable an-
gina undergoing a single-vessel intervention (22).
Nevertheless, a direct relationship between positive
remodeling and worse clinical outcomes has not
been proved, especially in NCLs. The current study
Table 5. Independent Predictors of Nonculprit Major Adverse Cardiac Events
at the Lesion Level
Hazard Ratio
(95% Conﬁdence Interval) p Value
RI <0.88 vs. RI 0.88–1.00 2.39 (1.07–5.34) 0.033
RI >1.00 vs. RI 0.88–1.00 2.34 (1.00–5.44) 0.049
Plaque burden $70% 5.03 (2.44–10.35) <0.0001
Virtual histology thin-cap ﬁbroatheroma 3.05 (1.63–5.71) 0.0005
Minimum lumen area #4 mm2 3.04 (1.51–6.13) 0.0018
Variables entered were RI <0.88 vs. RI 0.88–1.00, RI >1.00 vs. RI 0.88–1.00 and previously published
PROSPECT predictors (plaque burden $70%, virtual histology thin-cap ﬁbroatheroma, minimum lumen
area #4 mm2).
RI ¼ remodeling index.
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77extends previous studies and supports the concept
that positive remodeling is an independent predic-
tor of subsequent NCL MACE in PROSPECT
patients.
Negative remodeling. In the present study, the
mean remodeling index in the negatively remodeled
lesions was 0.77, signiﬁcantly lower than in previous
studies (1,3,4). Moreover, in the present study,
compared with positive remodeling lesions, negative
remodeling lesions were longer and more calciﬁed,
consistent with advanced plaques, also similar to
previous studies (9,23). Negative remodeling lesions
also had the most severe stenosis. Our data were
consistent with those of previous IVUS studies in
which negative remodeling was a major contributor
to luminal narrowing in more advanced disease
(9,24). However, surprisingly, plaques with negative
remodeling also had the greatest frequency of VH-
TCFA, especially VH-TCFA with multiple NCs.
The presence of multiple NCs was consistent with
more advanced atherosclerosis in which there had
been a recurring cycle of rupture and healing,
as suggested by Burke et al. (25). Thus, negative
remodeling was a marker of more advanced
atherosclerosis to explain its ability to predict of
NCL MACE (26).
Clinical events. Most events in both positive and
negative remodeling lesions were rehospitalization
due to unstable or progressive angina. However, the
process of the development of cardiac events might
have been different between negative and positive
remodeling lesions. Negative remodeling physio-
logically contributed to symptomatic signiﬁcant
stenosis formation and the need for revasculariza-
tion (7,9,24,26). On the other hand, positive
remodeling lesions might have represented purely
morphologically unstable disease. Pasterkamp et al.
(27) demonstrated that local inﬂammation of the
cap and shoulder of the plaque, promoting plaquevulnerability, was more common in positive
remodeling.
Study limitations. In the present study, IVUS
analysis was performed at only 1 time point. Thus,
these results do not reﬂect the dynamic interchange
between remodeling and morphological behavior
and its natural history. We investigated the rela-
tionship between remodeling and clinical outcomes
in lesions with $40% plaque burden. Therefore,
its relation in the early stage of atherosclerosis
in vivo is still unclear.CONCLUS IONS
Two different patterns of remodeling, not only
positive remodeling, but also negative remodeling,
were associated with future cardiovascular events in
the PROSPECT study.
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